logo

FDA Calendar

Share SHARE
Company Name Ligand Pharmaceuticals Inc
Drug Name LUXTURNA (BLA)
Event Name FDA decision on LUXTURNA for inherited retinal disease
Event Date 01/12/2018
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar